1. 101PEffect on oxaliplatin-free interval for successful rechallenge of oxaliplatin in colorectal cancer patients who had experienced an oxaliplatin: Related hypersensitivity reaction. (25th November 2018) Authors: Horasawa, S; Kaneko, A; Kotani, D; Nakashima, S; Bando, H; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 106PSafety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer. (25th November 2018) Authors: Kotani, D; Kuboki, Y; Yasuda, K; Nakamura, Y; Kawazoe, A; Bando, H; Taniguchi, H; Shitara, K; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 607TiPBIG BANG study: A multicenter phase II study of the MEK inhibitor binimetinib + BRAF inhibitor encorafenib + anti-EGFR antibody cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer (EPOC 1703). (23rd October 2018) Authors: Kotani, D; Bando, H; Masuishi, T; Komatsu, Y; Yamaguchi, K; Nakajima, T E; Satoh, T; Nishina, T; Esaki, T; Nomura, S; Sakamoto, S; Iida, S; Matsuda, S; Yonemura, M; Fuse, N; Sato, A; Fujii, S; Ebi, H; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 608TiPBRAVERY study: A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer (EPOC1701). (23rd October 2018) Authors: Masuishi, T; Taniguchi, H; Kotani, D; Bando, H; Komatsu, Y; Yamaguchi, K; Nakajima, T E; Satoh, T; Nishina, T; Esaki, T; Wakabayashi, M; Nomura, S; Sakamoto, S; Ono, H; Hirano, N; Fujishiro, N; Fuse, N; Sato, A; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Issue 5 (12th March 2020) Authors: Tsukamoto, S; Fujita, S; Ota, M; Mizusawa, J; Shida, D; Kanemitsu, Y; Ito, M; Shiomi, A; Komori, K; Ohue, M; Akazai, Y; Shiozawa, M; Yamaguchi, T; Bando, H; Tsuchida, A; Okamura, S; Akagi, Y; Takiguchi, N; Saida, Y; Akasu, T Journal: British journal of surgery Issue: Volume 107:Issue 5(2020) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O-005A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer. (20th June 2018) Authors: Kagawa, Y; Kato, T; Bando, H; Akagi, K; Denda, T; Nishina, T; Komatsu, Y; Oki, E; Kudo, T; Yamanaka, T; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O-010VOLTAGE: Investigator-initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer. (2nd July 2019) Authors: Yoshino, T; Bando, H; Tsukada, Y; Inamori, K; Yuki, S; Komatsu, Y; Homma, S; Uemura, M; Kato, T; Kotani, D; Fukuoka, S; Sasaki, T; Nishizawa, Y; Nakamura, N; Wakabayashi, M; Kojima, M; Togashi, Y; Sato, A; Nishikawa, H; Ito, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O-028Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for stage III colon cancer: ACHIEVE as part of the IDEA collaboration. (20th June 2018) Authors: Takeuchi, S; Yoshino, T; Yamanaka, T; Kotaka, M; Manaka, D; Eto, T; Hasegawa, J; Takagane, A; Nakamura, M; Kato, T; Munemoto, Y; Bando, H; Taniguchi, H; Gamoh, M; Shiozawa, M; Saji, S; Maehara, Y; Mizushima, T; Ohtsu, A; Mori, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-228VOLTAGE: Multicenter phase Ib/II study of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy (CRT) with capecitabine in patients with locally advanced rectal cancer (LARC). (20th June 2018) Authors: Bando, H; Tsukada, Y; Inamori, K; Fukuoka, S; Sasaki, T; Nishizawa, Y; Wakabayashi, M; Kojima, M; Togashi, Y; Yuki, S; Komatsu, Y; Homma, S; Hatanaka, Y; Matsuno, Y; Uemura, M; Kato, T; Sato, A; Nishikawa, H; Ito, M; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-228VOLTAGE: Multicenter phase Ib/II study of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy (CRT) with capecitabine in patients with locally advanced rectal cancer (LARC). (20th June 2018) Authors: Bando, H; Tsukada, Y; Inamori, K; Fukuoka, S; Sasaki, T; Nishizawa, Y; Wakabayashi, M; Kojima, M; Togashi, Y; Yuki, S; Komatsu, Y; Homma, S; Hatanaka, Y; Matsuno, Y; Uemura, M; Kato, T; Sato, A; Nishikawa, H; Ito, M; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗